Uveal Melanoma Treatment Industry Overview
The uveal melanoma treatment market is fragmented in nature due to the presence of several companies operating globally and regionally. The competitive landscape includes an analysis of a few international and local companies that hold significant market share and are well known, including Eli Lilly and Company, Novartis AG, Bayer AG, Immunocore Holdings PLC, AstraZeneca, IDEAYA Biosciences Inc., Merck & Co. Inc., DAIICHI SANKYO COMPANY, iOnctura, and Bristol-Myers Squibb.
Uveal Melanoma Treatment Market Leaders
-
Eli Lilly and Company
-
Novartis AG
-
Bayer AG
-
AstraZeneca
-
Bristol-Myers Squibb
- *Disclaimer: Major Players sorted in no particular order